Search Results 1691-1700 of 14713 for anti-TNF drugs

  1. Torsemide (Intravenous Route) Description and Brand Names - Mayo Clinic

    Torsemide belongs to the group of medicines called loop diuretics. Torsemide is given to help reduce the amount of water in the body associated with congestive ...

  2. Glycopyrrolate And Formoterol (Inhalation Route) Description and Brand Names - Mayo Clinic

    Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs. They relieve cough, wheezing, ...

  3. Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer - Mayo Clinic

    It is anticipated that the combination of drugs will improve survival and have few side effects. ... No concurrent anti-cancer treatment of any type. Patients ...

  4. Atezolizumab (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Lindane (Topical Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. Lindane is poisonous. Keep it away from the mouth because it is harmful and may ...

  6. Interferon Alfa-2b (Injection Route) Precautions - Mayo Clinic

    These medicines may also cause birth defects if the father is using it when his sexual partner becomes pregnant. If a pregnancy occurs while you are using these ...

  7. PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination - Mayo Clinic

    Known hypersensitivity to the study drugs; Treatment with any anti-cancer agents within 28 days of study entry; Presence of clinically evident active CNS ...

  8. Strategy for Improving Stroke Treatment Response - Mayo Clinic

    ... anti-platelet treatment. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 06/06/2024. Questions regarding ...

  9. Infectious Diseases - Overview - Mayo Clinic

    This therapy significantly reduced the hospitalization rate and decreased mortality of people showing symptoms of infection with the virus that causes COVID-19 ...

  10. A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Participation eligibility · Has received any of the following therapies: daratumumab or other anti-CD38 therapies · Has received anti-myeloma treatment within 2 ...